{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T10:07:40Z","timestamp":1793614060159,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T00:00:00Z","timestamp":1591315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T00:00:00Z","timestamp":1591315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Many autoimmune diseases share common pathogenic mechanisms, cytokine pathways and systemic inflammatory cascades; however, large studies quantifying the co-existence of autoimmune diseases in patients with juvenile idiopathic arthritis (JIA) have not been conducted.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We performed a cross-sectional study using two United States administrative healthcare claims databases (Truven Health MarketScan\u00ae Commercial Database and IMS PharMetrics database) to screen for the prevalence of multiple autoimmune diseases in patients with JIA and in a control group with attention deficit hyperactivity disorder (ADHD). Patients with a diagnosis code for JIA or ADHD between January 1, 2006 and September 30, 2017 were separated into two age cohorts (&lt;\u200918 and\u2009\u2265\u200918\u2009years) and matched (maximum 1:5) based on age, sex, number of medical encounters, and calendar year of diagnosis. The prevalence rates of 30 pre-specified autoimmune diseases during the 12-month periods before and after diagnosis were compared.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Overall, 29,215 patients with JIA and 134,625 matched control patients with ADHD were evaluated. Among patients in the MarketScan database, 28\/30 autoimmune diseases were more prevalent in patients with JIA aged &lt;\u200918\u2009years and 29\/30 were more prevalent in patients aged \u2265\u00a018\u2009years when compared with a matched cohort of patients with ADHD. In the PharMetrics database, 29\/30 and 30\/30 autoimmune diseases were more prevalent in patients with JIA aged &lt;\u200918 and\u2009\u2265\u200918\u2009years, respectively, compared with a matched cohort of patients with ADHD. Among patients with JIA aged &lt;\u200918\u2009years, the greatest odds ratios (ORs) were seen for Sj\u00f6gren\u2019s syndrome\/sicca syndrome and uveitis. Among patients aged \u2265\u00a018\u2009years in the MarketScan database, the greatest ORs were recorded for uveitis. Data from the PharMetrics database indicated that the greatest ORs were for uveitis and chronic glomerulonephritis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Patients with JIA are more likely to have concurrent autoimmune diseases than matched patients with ADHD. Having an awareness of the co-existence of autoimmune diseases among patients with JIA may play an important role in patient management, treatment decisions, and outcomes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>Not applicable.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12969-020-00426-9","type":"journal-article","created":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T12:02:43Z","timestamp":1591358563000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Prevalence of co-existing autoimmune disease in juvenile idiopathic arthritis: a cross-sectional study"],"prefix":"10.1186","volume":"18","author":[{"given":"Teresa A.","family":"Simon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gowri Priya","family":"Harikrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh","family":"Kawabata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanket","family":"Singhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermine I.","family":"Brunner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Lovell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,5]]},"reference":[{"key":"426_CR1","unstructured":"American Autoimmune Related Diseases Association Inc. Autoimmune Disease Statistics. Available from: https:\/\/www.aarda.org\/news-information\/statistics\/#1488234386508-a9560084-9b69. Accessed 2019."},{"issue":"3","key":"426_CR2","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1006\/clin.1997.4412","volume":"84","author":"DL Jacobsen","year":"1997","unstructured":"Jacobsen DL, Gange SJ, Rose NR, Graham NM. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol. 1997;84(3):223\u201343.","journal-title":"Clin Immunol Immunopathol"},{"issue":"3\u20134","key":"426_CR3","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jaut.2009.09.008","volume":"33","author":"GS Cooper","year":"2009","unstructured":"Cooper GS, Bynum ML, Somers EC. Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases. J Autoimmun. 2009;33(3\u20134):197\u2013207.","journal-title":"J Autoimmun"},{"issue":"4","key":"426_CR4","doi-asserted-by":"publisher","first-page":"151","DOI":"10.12691\/ijcd-3-4-8","volume":"3","author":"A Lerner","year":"2015","unstructured":"Lerner A, Jeremias P, Matthias T. The world incidence and prevalence of autoimmune diseases is increasing. Int J Celiac Dis. 2015;3(4):151\u20135.","journal-title":"Int J Celiac Dis"},{"key":"426_CR5","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.2105\/AJPH.2009.180273","volume":"100","author":"SL Thomas","year":"2010","unstructured":"Thomas SL, Griffith C, Smeeth L, Rooney C, Hall AJ. Burden of mortality associated with autoimmune diseases among females in the United Kingdom. Am J Public Health. 2010;100:2279\u201387.","journal-title":"Am J Public Health"},{"issue":"3","key":"426_CR6","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1002\/1529-0131(200103)44:3<523::AID-ANR99>3.0.CO;2-1","volume":"44","author":"AR French","year":"2001","unstructured":"French AR, Mason T, Nelson AM, O'Fallon WM, Gabriel S. Increased mortality in adults with a history of juvenile rheumatoid arthritis. Arth Rheum. 2001;44(3):523\u20137.","journal-title":"Arth Rheum."},{"key":"426_CR7","unstructured":"The American Autoimmune Related Diseases Association. Autoimmune disease list. Available from: https:\/\/www.aarda.org\/diseaselist\/. Accessed 2019."},{"issue":"7","key":"426_CR8","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/nm.3897","volume":"21","author":"JH Cho","year":"2015","unstructured":"Cho JH, Feldman M. Heterogeneity of autoimmune diseases: pathophysiologic insights from genetics and implications for new therapies. Nat Med. 2015;21(7):730\u20138.","journal-title":"Nat Med"},{"issue":"7539","key":"426_CR9","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature13835","volume":"518","author":"KK Farh","year":"2015","unstructured":"Farh KK, Marson A, Zhu J, Kleinewietfeld M, Housley WJ, Beik S, et al. Genetic and epigenetic fine mapping of causal autoimmune disease variants. Nature. 2015;518(7539):337\u201343.","journal-title":"Nature."},{"key":"426_CR10","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2147\/JMDH.S79384","volume":"8","author":"MA Kumarasamy","year":"2015","unstructured":"Kumarasamy MA, Sanfilippo FP. Breaking down silos: engaging students to help fix the US health care system. J Multidiscip Healthc. 2015;8:101\u20138.","journal-title":"J Multidiscip Healthc"},{"issue":"9563","key":"426_CR11","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/S0140-6736(07)60363-8","volume":"369","author":"A Ravelli","year":"2007","unstructured":"Ravelli A, Martini A. Juvenile idiopathic arthritis. Lancet. 2007;369(9563):767\u201378.","journal-title":"Lancet."},{"key":"426_CR12","doi-asserted-by":"publisher","first-page":"c6434","DOI":"10.1136\/bmj.c6434","volume":"341","author":"FHM Prince","year":"2010","unstructured":"Prince FHM, Otten MH, van Suijlekom-Smit LWA. Diagnosis and management of juvenile idiopathic arthritis. BMJ. 2010;341:c6434.","journal-title":"BMJ."},{"issue":"5","key":"426_CR13","doi-asserted-by":"publisher","first-page":"715","DOI":"10.3899\/jrheum.120602","volume":"40","author":"L Bertilsson","year":"2013","unstructured":"Bertilsson L, Andersson-Gare B, Fasth A, Petersson IF, Forsblad-D'elia H. Disease course, outcome, and predictors of outcome in a population-based juvenile chronic arthritis cohort followed for 17 years. J Rheumatol. 2013;40(5):715\u201324.","journal-title":"J Rheumatol"},{"issue":"1","key":"426_CR14","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1136\/annrheumdis-2014-206034","volume":"75","author":"AM Selvaag","year":"2016","unstructured":"Selvaag AM, Aulie HA, Lilleby V, Flato B. Disease progression into adulthood and predictors of long-term active disease in juvenile idiopathic arthritis. Ann Rheum Dis. 2016;75(1):190\u20135.","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"426_CR15","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1007\/s12325-017-0627-3","volume":"34","author":"TA Simon","year":"2017","unstructured":"Simon TA, Kawabata H, Ray N, Baheti A, Suissa S, Esdaile JM. Prevalence of co-existing autoimmune disease in rheumatoid arthritis: a cross-sectional study. Adv Ther. 2017;34(11):2481\u201390.","journal-title":"Adv Ther"},{"issue":"2","key":"426_CR16","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jbspin.2013.09.003","volume":"81","author":"S Thierry","year":"2014","unstructured":"Thierry S, Fautrel B, Lemelle I, Guillemin F. Prevalence and incidence of juvenile idiopathic arthritis: a systematic review. Joint Bone Spine. 2014;81(2):112\u20137.","journal-title":"Joint Bone Spine"},{"issue":"12","key":"426_CR17","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.3899\/jrheum.130302","volume":"40","author":"ST Angeles-Han","year":"2013","unstructured":"Angeles-Han ST, Pelajo CF, Vogler LB, Rouster-Stevens K, Kennedy C, Ponder L, et al. Risk markers of juvenile idiopathic arthritis-associated uveitis in the childhood arthritis and rheumatology research Alliance (CARRA) registry. J Rheumatol. 2013;40(12):2088\u201396.","journal-title":"J Rheumatol"},{"issue":"3","key":"426_CR18","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1002\/art.20945","volume":"52","author":"A Ravelli","year":"2005","unstructured":"Ravelli A, Felici E, Magni-Manzoni S, Pistorio A, Novarini C, Bozzola E, et al. Patients with antinuclear antibody\u2013positive juvenile idiopathic arthritis constitute a homogeneous subgroup irrespective of the course of joint disease. Arthritis Rheumatism. 2005;52(3):826\u201332.","journal-title":"Arthritis Rheumatism"},{"issue":"6","key":"426_CR19","first-page":"568","volume":"40","author":"S Agrawal","year":"2003","unstructured":"Agrawal S, Desai MP. Simultaneous occurrence of type I diabetes mellitus and juvenile rheumatoid arthritis. Indian Pediatr. 2003;40(6):568\u201371.","journal-title":"Indian Pediatr"},{"issue":"5","key":"426_CR20","first-page":"2","volume":"2011","author":"VM Marques","year":"2011","unstructured":"Marques VM, Carvalho SC, Antunes AM, Marques OA, Silva MH, Vieira MJ. Graves\u2019 disease associated with juvenile idiopathic arthritis. Rev Bras Reumatol. 2011;2011(5):2.","journal-title":"Rev Bras Reumatol"},{"issue":"8","key":"426_CR21","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1111\/j.1399-5448.2010.00676.x","volume":"11","author":"KH Nagy","year":"2010","unstructured":"Nagy KH, Lukacs K, Sipos P, Hermann R, Madacsy L, Soltesz G. Type 1 diabetes associated with Hashimoto's thyroiditis and juvenile rheumatoid arthritis: a case report with clinical and genetic investigations. Pediatr Diabetes. 2010;11(8):579\u201382.","journal-title":"Pediatr Diabetes"},{"key":"426_CR22","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1093\/rheumatology\/keh531","volume":"44","author":"S Stagi","year":"2005","unstructured":"Stagi S, Giani T, Simonini G, Falcini F. Thyroid function, autoimmune thyroiditis and coeliac disease in juvenile idiopathic arthritis. Rheumatology. 2005;44:517\u201320.","journal-title":"Rheumatology."},{"key":"426_CR23","first-page":"310","volume":"31","author":"TC Robazzi","year":"2013","unstructured":"Robazzi TC, Adan LF, Pimentel K, Guimar\u00e3es I, Magalh\u00e3es Filho J, Toralles MB, et al. Autoimmune endocrine disorders and coeliac disease in children and adolescents with juvenile idiopathic arthritis and rheumatic fever. Clin Exp Rheumatol. 2013;31:310\u20137.","journal-title":"Clin Exp Rheumatol"},{"key":"426_CR24","first-page":"565","volume":"20","author":"MG Alpigiani","year":"2002","unstructured":"Alpigiani MG, Cerboni M, Bertini I, d'Annunzio G, Haupt R, Iester A, et al. Endocrine autoimmunity in young patients with juvenile chronic arthritis. Clin Exp Immunol. 2002;20:565\u20138.","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"426_CR25","first-page":"462","volume":"50","author":"E Unsal","year":"2008","unstructured":"Unsal E, Oren O, Salar K, Makay B, Abaci A, Ozhan B, et al. The frequency of autoimmune thyroid disorders in juvenile idiopathic arthritis. Turk J Pediatr. 2008;50(5):462\u20135.","journal-title":"Turk J Pediatr"},{"key":"426_CR26","doi-asserted-by":"crossref","unstructured":"Mihailova D, Grigorova R, Vassileva B, Mladenoa G, Ivanona N, Stephanov S, et al. Autoimmune thyroid disorders in juvenile chronic arthritis and systemic lupus erythematosus. Rheumaderm. 1999;455:55\u201360.","DOI":"10.1007\/978-1-4615-4857-7_8"},{"issue":"2","key":"426_CR27","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3899\/jrheum.110654","volume":"39","author":"H Pohjankoski","year":"2012","unstructured":"Pohjankoski H, Kautiainen H, Korppi M, Sovolainen A. Simultaneous juvenile idiopathic arthritis and diabetes mellitus type 1 \u2014 a Finnish Nationwide study. J Rheumatol. 2012;39(2):377\u201381.","journal-title":"J Rheumatol"},{"key":"426_CR28","doi-asserted-by":"crossref","unstructured":"Tronconi E, Miniaci A, Pession A. The autoimmune burden in juvenile idiopathic arthritis. Ital J Pediatr. 2017;43:56.","DOI":"10.1186\/s13052-017-0373-9"},{"issue":"5","key":"426_CR29","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.jaad.2012.04.039","volume":"67","author":"JJ Wu","year":"2012","unstructured":"Wu JJ, Nguyen TU, Poon KY, Herrinton LJ. The association of psoriasis with autoimmune diseases. J Am Acad Dermatol. 2012;67(5):924\u201330.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"426_CR30","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1177\/1352458514564490","volume":"21","author":"RA Marrie","year":"2015","unstructured":"Marrie RA, Reider N, Cohen J, Stuve O, Sorensen PS, Cutter G, et al. A systematic review of the incidence and prevalence of autoimmune disease in multiple sclerosis. Mult Scler. 2015;21(3):282\u201393.","journal-title":"Mult Scler"},{"issue":"3","key":"426_CR31","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/ar2669","volume":"11","author":"SE Gabriel","year":"2009","unstructured":"Gabriel SE, Michaud K. Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Res Ther. 2009;11(3):229.","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"426_CR32","first-page":"796","volume":"31","author":"A Raab","year":"2013","unstructured":"Raab A, Sengler C, Niewerth M, Klotsche J, Horneff G, Zink A, et al. Comorbidity profiles among adult patients with juvenile idiopathic arthritis: results of a biologic register. Clin Exp Rheumatol. 2013;31(5):796\u2013802.","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"426_CR33","doi-asserted-by":"publisher","first-page":"R666","DOI":"10.1186\/ar1724","volume":"7","author":"M Flendrie","year":"2005","unstructured":"Flendrie M, Vissers WH, Creemers MC, de Jong EM, van de Kerkhof PC, van Riel PL. Dermatological conditions during TNF-alpha-blocking therapy in patients with rheumatoid arthritis: a prospective study. Arthritis Res Ther. 2005;7(3):R666\u201376.","journal-title":"Arthritis Res Ther."},{"key":"426_CR34","doi-asserted-by":"crossref","unstructured":"Dendrou CA, Bell JI, Fugger L. A clinical conundrum: the detrimental effect of TNF antagonists in multiple sclerosis. Pharmacogenomics. 2013;14(12):1397\u2013404.","DOI":"10.2217\/pgs.13.140"},{"issue":"1","key":"426_CR35","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12969-016-0107-3","volume":"14","author":"ML Mannion","year":"2016","unstructured":"Mannion ML, Xie F, Baddley J, Chen L, Curtis JR, Saag K, et al. Analysis of health care claims during the peri-transfer stage of transition from pediatric to adult care among juvenile idiopathic arthritis patients. Pediatr Rheumatol. 2016;14(1):49.","journal-title":"Pediatr Rheumatol"},{"key":"426_CR36","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/978-3-662-45758-0_249","volume":"16","author":"M Matthews","year":"2014","unstructured":"Matthews M, Nigg JT, Fair DA. Attention deficit hyperactivity disorder. Curr Top Behav Neurosci. 2014;16:235\u201366.","journal-title":"Curr Top Behav Neurosci"},{"issue":"8","key":"426_CR37","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1002\/art.34458","volume":"64","author":"T Beukelman","year":"2012","unstructured":"Beukelman T, Xie F, Chen L, Baddley JW, Delzell E, Grijalva CG. Rates of hospitalized bacterial infection associated with juvenile idiopathic arthritis and its treatment. Arth Rheum. 2012;64(8):2773\u201380.","journal-title":"Arth Rheum"},{"issue":"1","key":"426_CR38","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1136\/amiajnl-2011-000376","volume":"19","author":"JM Overhage","year":"2012","unstructured":"Overhage JM, Ryan PB, Reich CG, Hartzema AG, Stang PE. Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc. 2012;19(1):54\u201360.","journal-title":"J Am Med Inform Assoc"},{"key":"426_CR39","unstructured":"International Society for Pharmacoepidemiology. Guidelines for Good Pharmacoepidemiology Practices (GPP). 2016. Available from: http:\/\/pharmacoepi.org\/resources\/guidelines_08027.cfm. Accessed 7 July 2016."},{"issue":"11","key":"426_CR40","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/0895-4356(94)90129-5","volume":"47","author":"M Charlson","year":"1994","unstructured":"Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47(11):1245\u201351.","journal-title":"J Clin Epidemiol"},{"key":"426_CR41","unstructured":"Wipfler K, Pedro, S, Shaw, Y, Schumacher, R, Simon, T, Dominique, A, Reinhardt, A, Michaud, K. Does diagnosis matter? Clinical distinctions between adult JIA and RA, and a characterization of patients with JIA reclassified as RA in adulthood. Atlanta: 2019 ACR\/ARP Annual Meeting; 2019."},{"key":"426_CR42","unstructured":"Gower T. All Grown up: juvenile idiopathic arthritis and rheumatoid arthritis: arthritis foundation. 2017. Available from: http:\/\/www.kidsgetarthritistoo.org\/living-with-ja\/daily-life\/transition\/juvenile-arthritis-transition-to-rheumatoid-arthritis.php. Accessed 2019."},{"issue":"6","key":"426_CR43","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1093\/aje\/kwn408","volume":"169","author":"EC Somers","year":"2009","unstructured":"Somers EC, Thomas SL, Smeeth L, Hall AJ. Are individuals with an autoimmune disease at higher risk of a second autoimmune disorder? Am J Epidemiol. 2009;169(6):749\u201355.","journal-title":"Am J Epidemiol"},{"issue":"7","key":"426_CR44","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1111\/1756-185X.13527","volume":"22","author":"SB Yong","year":"2019","unstructured":"Yong SB, Huang JY, Chiou JY, Wei JC. Adult outcome of juvenile idiopathic arthritis: a nationwide population-based retrospective cohort study in Taiwan. Int J Rheum Dis. 2019;22(7):1283\u20138.","journal-title":"Int J Rheum Dis"},{"issue":"7","key":"426_CR45","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1002\/art.10370","volume":"46","author":"S Prahalad","year":"2002","unstructured":"Prahalad S, Shear ES, Thompson SD, Giannini EH, Glass DN. Increased prevalence of familial autoimmunity in simplex and multiplex families with juvenile rheumatoid arthritis. Arthritis Rheum. 2002;46(7):1851\u20136.","journal-title":"Arthritis Rheum"},{"key":"426_CR46","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jaut.2015.08.002","volume":"64","author":"AO Hersh","year":"2015","unstructured":"Hersh AO, Prahalad S. Immunogenetics of juvenile idiopathic arthritis: a comprehensive review. J Autoimmun. 2015;64:113\u201324.","journal-title":"J Autoimmun"},{"issue":"7","key":"426_CR47","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1002\/art.24618","volume":"60","author":"S Prahalad","year":"2009","unstructured":"Prahalad S, Hansen S, Whiting A, Guthery SL, Clifford B, McNally B, et al. Variants in TNFAIP3, STAT4, and C12orf30 loci associated with multiple autoimmune diseases are also associated with juvenile idiopathic arthritis. Arthritis Rheum. 2009;60(7):2124\u201330.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"426_CR48","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12969-016-0131-3","volume":"15","author":"A Migowa","year":"2017","unstructured":"Migowa A, Colmegna I, Hitchon C, Were E, Ng'ang'a E, Ngwiri T, et al. The spectrum of rheumatic in-patient diagnoses at a pediatric hospital in Kenya. Pediatr Rheumatol Online J. 2017;15(1):4.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"1","key":"426_CR49","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ijmedinf.2006.11.005","volume":"77","author":"J Stausberg","year":"2008","unstructured":"Stausberg J, Lehmann N, Kaczmarek D, Stein M. Reliability of diagnoses coding with ICD-10. Int J Med Inform. 2008;77(1):50\u20137.","journal-title":"Int J Med Inform"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-020-00426-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12969-020-00426-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-020-00426-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T23:17:20Z","timestamp":1622848640000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-020-00426-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,5]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["426"],"URL":"https:\/\/doi.org\/10.1186\/s12969-020-00426-9","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,5]]},"assertion":[{"value":"28 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the International Society for Pharmacoepidemiology Guidelines for Good Pharmacoepidemiology Practices, applicable regulatory requirements and the principles of the Declaration of Helsinki. No new studies with human or animal subjects are reported in this article. Review and approval by ethics committees and patient informed consent were not required for this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"TAS was an employee of Bristol\u00a0Myers Squibb at the time of the analysis (former employee at present). GPH and SS are consultants for Bristol\u00a0Myers Squibb. HK was an employee of Bristol\u00a0Myers Squibb at the time of the analysis (former employee at present) and is a consultant for Bristol\u00a0Myers Squibb. HIB has received consulting fees and\/or speakers bureau fees from Boehringer Ingelheim, Bristol\u00a0Myers Squibb, EMD Serono, Genentech, Janssen, Lilly, Novartis, Pfizer, Roche, R-Pharm, and UCB; and has received research funds from Pfizer. Cincinnati Children\u2019s Hospital Medical Center has received consulting fees and\/or honoraria for the work of HIB from Abbott, Amgen, AstraZeneca, Boehringer Ingelheim, Bristol\u00a0Myers Squibb, EMD Serono, GlaxoSmithKline, Hoffman-La Roche, Janssen, Lilly, Novartis, Pfizer, Takeda, UBC, and Wyeth Pharma. DJL\u2019s institution, Cincinnati Children\u2019s Hospital Medical Center, has received consulting fees and\/or honoraria for the work of DJL from Amgen, Abbott, AstraZeneca, Boehringer Ingelheim, Bristol\u00a0Myers Squibb, Celgene, GlaxoSmithKline, Hoffman-La Roche, Janssen, Novartis, Pfizer, Takeda, UBC, and Wyeth Pharma.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"43"}}